Arch Biopartners Inc. V.ARCH

@ the Bell: TSX scores modest gains

[Jon Brown]

Canada’s main stock index closed in the green on Tuesday, as traders waited to see if the Bank of Canada would hold or hike interest rate. read article.

[Jon Brown]

Futures for Canada’s main stock index slid south on Monday, burdened by health-care stocks, investors await Bank of Canada’s rate decision. read article.

[Jon Brown]

Investors often keep focused on the most consistent plays, when times of renewed uncertainty rears its head in the markets. read article.

[Viking2233]

I started position this week and have added to position each day. We continue to hit new 52 week lows daily. I just cannot understand tge selling pressure as I only see tremendous upside.  How

[Viking2233]

Some nice buying action final 30 minutes, looks lije someone trying accumulate at house 83. Also two large 50k bids moving up and been there for a about a week. Possibly news coming soon, which would

[Viking2233]

Does anyone have any explanation for the daily shorting on this stock for the past 6 months? The 1 year chart is ugly st best, the short reports do not correlate with the shorting action.  Do

[Cb27743]

I agree, it’s crucial to acknowledge the concerns raised by investors regarding the delay publishing the Phase 2 data. The lack of transparency and communication on this matter has left shareholders

[Viking2233]

Hello, I have been looking into this company and its potential upside. There are numerous positive aspects such as successful trials, increased dosage study and $5B annual sales market for AKI. The

[Riverfolk]

 Nice coverage by Reuters this morning:   * ARCH BIOPARTNERS ANNOUNCES POSITIVE RESULTS OF DOSE ESCALATION HUMAN TRIAL FOR LSALT PEPTIDE   * ARCH BIOPARTNERS -RAISED MAXIMUM

[Riverfolk]

Arch Successfully completes dose escalation trial

[PressRelease]

TORONTO, April 18, 2023 (GLOBE NEWSWIRE) -- Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of novel therapeutics targeting organ inflammation, announced that it has safely increased the maximum...read article.

[TechTitan]

The same old copy and paste post crack me up! What are you trying to gain from this? 

[Riverfolk]

Arch scientists have demonstrated Metablok’s ability to block the inflammatory response triggered in the lung and liver with lipopolysaccharide (LPS) induced inflammation and in the kidney

[Riverfolk]

Inflammation Based Disease Inflammation is a localized physical condition that involves the activation of the immune system in response to infection, tissue injury, or autoimmunity. Inflammation is

[Riverfolk]

Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury https://www.ncbi.nlm.nih.gov

[Riverfolk]

LSALT Peptide Team

[Riverfolk]

Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury https://www.science.org

[Riverfolk]

Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver https://www.cell.com